|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.86 USD | -0.07% |
|
+0.44% | +80.20% |
| Market Cap | 8.9B 7.7B 7.19B 6.6B 12.41B 847B 12.6B 84.36B 33.11B 425B 33.43B 32.69B 1,404B | P/E 2026 * |
-17.8x | P/E 2027 * | -20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.87B 6.8B 6.35B 5.83B 10.96B 749B 11.14B 74.55B 29.26B 375B 29.54B 28.89B 1,240B | EV / Sales 2026 * |
134x | EV / Sales 2027 * | 46.7x |
| Free-Float |
98.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | -0.07% | ||
| 1 week | +0.44% | ||
| Current month | +0.44% | ||
| 1 month | +0.42% | ||
| 3 months | +92.88% | ||
| 6 months | +82.32% | ||
| Current year | +80.20% |
| 1 week | 83.62 |  | 84.08 |
| 1 month | 83.44 | | 84.08 |
| Current year | 32.3 | | 84.08 |
| 1 year | 25.83 | | 84.08 |
| 3 years | 15.76 | | 84.08 |
| 5 years | 15.23 | | 84.08 |
| 10 years | 10.63 | | 84.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% | ||
| 2/23/26 | Free | Chief Financial Officer | 82,000 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | +0.44% | +200.88% | +366.03% | 8.9B | |
| +8.49% | +23.38% | +65.44% | +104.90% | 62.92B | |
| +1.25% | +2.44% | +32.55% | +72.63% | 54.32B | |
| +2.65% | +3.13% | -16.11% | -5.16% | 22.91B | |
| -0.72% | +33.25% | +20.20% | +500.73% | 28.73B | |
| +10.83% | +21.32% | +45.03% | +2.02% | 21.65B | |
| +6.50% | +7.56% | +38.20% | -21.33% | 17.76B | |
| -3.88% | +20.98% | +201.07% | +350.94% | 16.47B | |
| +6.20% | +12.16% | +28.51% | +629.05% | 15.48B | |
| +2.86% | +0.62% | +42.71% | +163.51% | 13.12B | |
| Average | +3.40% | +6.72% | +65.85% | +216.33% | 26.23B | |
| Weighted average by Cap. | +4.03% | +9.62% | +52.82% | +173.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.81M 50.87M 47.51M 43.58M 81.97M 5.6B 83.27M 557M 219M 2.81B 221M 216M 9.27B | 172M 149M 139M 128M 240M 16.39B 244M 1.63B 641M 8.21B 647M 632M 27.15B |
| Net income | -516M -447M -417M -383M -720M -49.15B -731M -4.89B -1.92B -24.64B -1.94B -1.9B -81.45B | -473M -409M -382M -350M -659M -44.98B -669M -4.48B -1.76B -22.54B -1.77B -1.74B -74.53B |
| Net Debt | -1.04B -895M -836M -767M -1.44B -98.51B -1.47B -9.81B -3.85B -49.37B -3.89B -3.8B -163B | -865M -748M -699M -641M -1.21B -82.34B -1.23B -8.2B -3.22B -41.27B -3.25B -3.18B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$83.88 | -0.05% | 1,080,799 |
| 26-08-06 | US$83.92 | -0.10% | 2,096,262 |
| 26-08-05 | US$84.00 | +0.17% | 2,866,831 |
| 26-08-04 | US$83.86 | +0.12% | 2,725,922 |
| 26-08-03 | US$83.76 | +0.29% | 1,745,072 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
